Asaf Danziger - 26 Nov 2021 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: Chief Executive Officer, Director
Signature: By: /s/ Steven Robbins, Attorney in Fact for Asaf Danziger
Issuer symbol: NVCR
Transactions as of: 26 Nov 2021
Net transactions value: +$509,539
Form type: 4
Filing time: 29 Nov 2021, 15:48:17 UTC
Previous filing: 08 Jul 2021
Next filing: 12 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Purchase	$396,133	+3,870	+47%	$102.36	12,172	26 Nov 2021	Direct	F1
transaction	NVCR	Ordinary Shares	Purchase	$103,370	+1,000	+8.2%	$103.37	13,172	26 Nov 2021	Direct
transaction	NVCR	Ordinary Shares	Purchase	$10,036	+104	+0.79%	$96.50	13,276	26 Nov 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On November 26, 2021, Mr. Danziger purchased 3,870 shares in multiple trades at prices ranging from $102.00 to $102.60. The price reported above reflects the weighted average purchase price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

Content

On November 26, 2021, Mr. Danziger purchased 3,870 shares in multiple trades at prices ranging from $102.00 to $102.60. The price reported above reflects the weighted average purchase price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.